WISHBONE MEDICAL NAMES JODIE N. HEGGELUND GLOBAL PRESIDENT OF SPINE & BIOLOGICS
WARSAW, Ind., September 2, 2020 — WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, announced this morning that Jodie N. Heggelund will serve as the company’s Global President of Spine & Biologics, effective immediately.
Building on recent acquisitions, WishBone is positioned to transform pediatric spine surgery with a platform of anatomically appropriate solutions designed to streamline OR efficiencies, eliminate variability, and improve clinical outcomes. The company’s “single-use” business model will enable WishBone to equip surgeons globally with sterile packed procedure kits to treat pediatric patients suffering from spinal deformities.
“I am honored to join WishBone Medical in serving the community of caregivers, clinicians and surgeons alike as we work to improve the quality of life for children around the world,” says Heggelund. “WishBone’s unique approach to providing pediatric-specific solutions in sterile packed kits provides surgical teams with the proper safeguards to ensure patient safety, most efficiently. Coupling this model with the development of spinal deformity systems designed for skeletally immature patients will further set WishBone ahead as a leading manufacturer of pediatric orthopedic solutions.”
Heggelund brings 20 years of experience across the spine, orthopedic and biologics market segments, having served various roles within finance, marketing, business development, project management, sales and sales management. His career in orthopedics started with Medtronic Spine in 2000, followed by Nuvasive, Orthofix and LDR Spine (now Zimmer Biomet). Since then, Jodie managed hybrid sales organizations—overseeing direct- and agent sales as well as multiple (OEM / Private Label) channel partners. Most recently, he served as VP of Sales, Central US & Pacific NW, for Xtant Medical. Over his extensive career, Jodie led commercialization efforts for over 30 products from concept to market and was responsible for $25 million to upwards of $100 million in revenues.
“WishBone’s Sterile SpineTM Systems are taking off with momentum that will only build in the months to come, and our versatile biologics offerings will expand soon after. The WishBone Spine and Biologics Divisions called for a decisive leader to ensure smooth operations as we continue to scale… As a proven expert with a multifaceted background in spine and biologics, it was clear that Jodie was our person. We cannot wait to see WishBone spine initiatives flourish under his leadership.”
-Kevin Blue, Chief Revenue Officer, WishBone Medical
Jodie holds an MBA and a Leadership Development Certification through Texas Tech’s Executive MBA program in addition to a BBA in Finance from Texas State University. Beyond industry experience and a formal education, Jodie is an active volunteer and contributor for the Texas Scottish Rite Hospital for Children and the St. Jude Children’s Research Hospital.
About WishBone Medical
WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, instruments and biologics in single-use, sterile packed procedure kits, designed to prevent infection, reduce overall costs for customers and achieve the best outcomes for children around the world who are still growing. The WishBone Medical Family of Companies offers 42 product systems with operations in Warsaw, IN, Istanbul, and Singapore.
For further information, visit www.wishbone-medical-migration.mysites.io or contact Kaitlyn Hughes, Director of Marketing & Communications, at +1-574-306-4006.
EY Announces Nick Deeter of WishBone Medical as an Entrepreneur Of The Year® 2020 Midwest Award Finalist
Ernst & Young LLP (EY US) recently announced that Nick Deeter of WishBone Medical was named an Entrepreneur Of The Year® 2020 Midwest Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. Deeter was selected as one of 22 finalists from a competitive pool of nominations by a panel of independent judges.
Award winners will be announced through a special virtual event in early October and will join a lifelong community of esteemed Entrepreneur Of The Year alumni from around the world. This year, unstoppable entrepreneurs who have provided extraordinary support for their communities, employees and others during the COVID-19 crisis will also be recognized for their courage, resilience and ingenuity.
Entrepreneur Of The Year is one of the preeminent competitive award programs for entrepreneurs and leaders of high-growth companies. The nominees are evaluated based on six criteria, including overcoming adversity; financial performance; societal impact and commitment to building a values-based company; innovation; and talent management. Since its launch, the program has expanded to recognize business leaders in more than 145 cities in over 60 countries around the world.
“It is truly an honor to be in the company of the exceptional individuals [selected finalists] working to improve the world through their own unique innovations. For me, this recognition is an added bonus to being on the verge of reaching my ultimate dream of improving the lives of children with orthopedic issues. While my career has centered on raising surgical standards for kids since 2006, my past company was limited in providing solutions to more than an exclusive list of hospitals. Even today, 95% of these children are not receiving the treatment that they need. WishBone Medical has become a huge catalyst to making FDA-cleared, anatomically appropriate implants more accessible to pediatric patients than ever before, with our single-use, sterile packed procedure kits. To me, recognition from a prestigious group like Ernst & Young tells me that the awareness of the need for these crucial solutions is quickly spreading—which is the most exciting part of this.”
– Nick Deeter, Founder & CEO, WishBone Medical
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National Awards, to be announced in November during a virtual awards gala. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2021.
Entrepreneur Of The Year Award winners become lifetime members of a global, multi-industry community of entrepreneurs, with exclusive, ongoing access to the experience, insight and wisdom of program alumni and other ecosystem members in over 60 countries — all supported by vast EY resources.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America and the Kauffman Foundation.
In the Midwest, sponsors also include LaSalle Network, Cresa, PNC Bank, Becker Professional Education and 1871.
About Entrepreneur Of The Year®
Entrepreneur Of The Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. Winners go on to compete for the EY World Entrepreneur Of The Year™ title. ey.com/us/eoy
About EY Private
As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/private
About EY
EY is a global leader in assurance, tax, strategy, transaction and consulting services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. For more information about our organization, please visit ey.com.
About WishBone Medical
WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, instruments and biologics in single-use, sterile packed procedure kits, designed to prevent infection, reduce overall costs for customers and achieve the best outcomes for children around the world who are still growing. The WishBone Medical Family of Companies offers 42 product systems with operations in Warsaw, IN, Istanbul, and Singapore. For further information, visit www.wishbone-medical-migration.mysites.io or contact Kaitlyn Hughes, Director of Marketing & Communications, at +1-574-306-4006.
WISHBONE MEDICAL ANNOUNCES STERILE SPINE OFFERINGS WITH NEW ACQUISITIONS
Proprietary Technologies and New Partnerships Work to Raise the Bar for Pediatric Spine Solutions
WARSAW, Ind., AUGUST 5, 2020 — WishBone Medical Inc., pediatric orthopedic company focused globally on the unmet needs of children suffering from orthopedic issues, today announced its 5th and 6th strategic acquisition in the past 18 months by acquiring substantially all assets of Back 2 Basics Direct (B2B) and Orbbö Surgical, two privately-held medical device companies focused on research, development and commercialization of sterile packaged implants and surgical instruments for spinal fusion.
“These acquisitions strengthen WishBone’s position in the pediatric orthopedic market with the addition of nine (9) FDA cleared, sterile packaged, spinal fusion product lines with year one revenue projections in excess of $12M,” stated Dr. Robert Wertz, Global VP of Market Development, Spine & Sports Medicine, WishBone Medical. “Also, our go-to-market plans include the addition of Back 2 Basics’ enhanced carbon composite biomaterials platform to our product development roadmap which will allow us to deliver an innovative pipeline of highly differentiated and disruptive technologies across our entire pediatric implant portfolio.”
Kevin Blue, Chief Revenue Officer of WishBone Medical, added, “Our entry into the pediatric spine segment marks yet another important milestone in our company’s history. We’re always looking to provide highly differentiated products that deliver clinical benefits with the potential to dramatically improve the lives of pediatric patients worldwide. These latest transactions will continue to position WishBone as the leading provider of sterile packed, anatomically appropriate procedure kits in the wake of the COVID-19 era.”
“We’re excited to join WishBone to further develop and commercialize our carbon composite technology platform as they bring to bear industry leading product innovation,” commented Louis Keppler, MD, Co-Founder of B2B. “Since 2015, our goal has been to improve surgical outcomes and expand indications with this disruptive technology. Together, we will better serve the market and change the lives of children everywhere.”
WishBone’s vertically integrated subsidiary, Red Star Medical Solutions (RSMS), provides the company with a key competitive advantage and dominant position within the $2.5B global pediatric orthopedic market by reducing time to market up to 65%* with in-house rapid prototyping, advanced manufacturing platforms and sterile packaging capabilities. RSMS is in discussion with the Indiana Economic Development Corporation (IEDC) to expand two of its production facilities in Whitley- and Marshall County, IN. WishBone will add to its global team of 165 with 20 new employees dedicated to the spine market segment and commercialize a full spectrum, enhanced carbon composite fiber product line for children who are still growing.
About Back 2 Basics
Based in Independence, Ohio, Back 2 Basics (B2B) was founded in 2015 by two board-certified, fellowship trained, orthopedic spine surgeons, Scot Miller, DO, MBA, and Louis Keppler, MD. With a combined 75 years of treating pediatric and adult patients and developing enhanced carbon composite materials for orthopedic applications, B2B is a privately held, sterile packaged, spinal implant manufacturer dedicated to Surgeon Driven Surgical Solutions.
About Orbbö Surgical
Based in Los Angeles, CA, Orbbö Surgical is a spine company founded with a focus on all aspects of today’s healthcare environment. Orbbö Surgical’s sterile packaged business model is designed to reduce risk of post-operative infection and increase operational efficiency within hospitals and ASCs to address the economic challenges of today. This results in a value-based care partnership between Orbbö Surgical and its partners.
About WishBone Medical
WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, instruments and biologics in single-use, sterile packed procedure kits, designed to prevent infection, reduce overall costs for customers and achieve the best outcomes for children around the world who are still growing. The WishBone Medical Family of Companies offers 42 product systems with operations in Warsaw, IN, Istanbul, and Singapore.
*Data on file
For further
information, visit www.wishbone-medical-migration.mysites.io or call Kaitlyn Hughes, Director of Marketing
& Communications,
at +1-574-306-4006.
VIZIENT, INC. AWARDS CONTRACT TO WISHBONE MEDICAL TO DELIVER ANATOMICALLY APPROPRIATE ORTHOPEDIC IMPLANTS & INSTRUMENTS TO SURGEONS CARING FOR CHILDREN
WARSAW, Ind., JULY 27, 2020 — WishBone Medical, a pediatric orthopedic company focused on innovative solutions designed around the unmet needs of children, announces a national agreement with Vizient, Inc., the largest member-driven health care performance improvement company in the United States. The agreement provides anatomically appropriate orthopedic solutions for arms, legs, spine, elbows, wrists and clavicles to surgeons caring for children.
“In the year 2020, there is still a huge technology deficit in the OR with 95%* of children receiving adult implants not cleared by the FDA for pediatric use. In some instances, these off-label applications can cause more harm than good. WishBone is thrilled about another game-changing opportunity to create greater access to solutions that are truly designed around the unmet needs of kids.”
– Nick Deeter, Founder and CEO, WishBone Medical
Vizient’s membership base comprises more than 50% of the nation’s acute care providers, which includes 95% of the nation’s academic medical centers, and more than 20% of ambulatory providers.
As possibly the only pediatric company in the world offering single-use, sterile packed procedure kits, WishBone customers are able to address supply chain obstacles and sterility issues inherent to reusable case and tray systems. The single-use model is crucial to making product accessible to Vizient member hospitals and surgery centers, while simplifying tracking and billing.
Through Vizient’s large membership base, WishBone’s “Just-In-Time” supply will allow health care facilities to benefit from immediate availability and shipment of product at contracted prices as needed.
“As surgeons take on a surge of cases post-COVID-19 pandemic, the need for single-use, sterile packed procedure kits has become increasingly apparent. The timing of this partnership could not be more serendipitous.”
– Kevin Blue, Chief Revenue Officer, WishBone Medical
In the $2.5B pediatric orthopedic market, by combining WishBone Medical’s single-use sterile kits for children with orthopedic issues with Vizient’s member hospitals and member ASC facilities, kids will finally receive anatomically appropriate solutions that they have always deserved.
About WishBone Medical
WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, instruments and biologics in sterile packed, single-use procedure kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing. Through recent acquisitions, WishBone Medical now offers 42 pediatric orthopedic product systems with operations in Warsaw, IN, Istanbul, Turkey, and Singapore.
*Data on file
For further information, visit www.wishbone-medical-migration.mysites.io or call Kaitlyn Hughes, Director of Marketing & Communications, at 574-306-4006.
WISHBONE MEDICAL ADDS RESORBABLE IMPLANTS TO PRODUCT OFFERINGS
FOR IMMEDIATE RELEASE
Contact:
Kaitlyn Hughes
574-306-4006
KHughes@wishbonemedical.com
wishbone-medical-migration.mysites.io
WISHBONE MEDICAL ADDS RESORBABLE IMPLANTS TO PRODUCT OFFERINGS
WishBone Medical Gains Distribution Rights to OsteoCrete®
WARSAW, Ind. AUGUST 15, 2019 — WishBone Medical announces a private label distribution agreement with Bone Solutions, Inc. (BSI) for worldwide rights within pediatric orthopedics to license and sell OsteoCrete® — the first FDA (510K) approved magnesium-based bone void filler in the orthopedic marketspace, designed to assist with bone repair and regeneration. Expanding beyond the original application, OsteoCrete® developers are now harnessing the product’s unique properties to create bioresorbable implants to ultimately replace many current metal technologies simultaneously improving patient outcomes.
Affording BSI the North American Bone Graft Technology Leadership of the Year Award in 2009, OsteoCrete® is an injectable, moldable solution to attach ligaments and tendons to bone, and bone-to-bone, with a robust composition that is three times stronger than cancellous bone.1
“This product is the holy grail for pediatric orthopedics as the resorbable properties eliminate the need for secondary operations,” says WishBone Founder and CEO, Nick Deeter. “Kids already harbor a lot of anxieties around the idea of surgery alone. If we can save patients and their families the expense and worries of follow-up procedures, that alone is a big win.”
“For so many years, the orthopedics industry demonstrated a clear demand for osteogenic implants which mimic properties of the human bone. Prior to OsteoCrete®, calcium-based solutions contributed to bone healing, but with little mechanical support,” explains BSI President and CEO, Drew Diaz. “Not only is OsteoCrete® 100% resorbable – it offers excellent bone remodeling during the window of healing with uncompromised strength.”
BSI surpassed 600 cases implanting OsteoCrete® this year with a 100% success rate. Moving forward, the company is focused on further development of bioresorbable implants and will continue exploring innovative applications for this unprecedented orthobiologics technology.
“While patients of all ages and stature benefit from OsteoCrete® advancements, the greatest improvement will be felt by children whose bodies are continually growing and changing,” adds Kevin Blue, WishBone’s Chief Revenue Officer. “Our team could not be more excited to offer such a clearly advantageous solution to better equip the surgeons caring for them.”
1. Bone Solutions’ Report 755635-01 Rev A, “Static Axial Compression Testing of the OsteoCrete System.”
About WishBone Medical
WishBone Medical is a global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single-use disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing. Through recent acquisitions, WishBone Medical now offers 42 pediatric orthopedic product systems with operations in Warsaw, IN, Istanbul, Turkey, and Singapore. For further information, visit wishbone-medical-migration.mysites.io or call Kaitlyn Hughes, Director of Marketing & Communications, at 574-306-4006.
About Bone Solutions Incorporated
Bone Solutions Inc. (‘BSI’) is an orthobiologics company with a vision to provide orthopedic surgeons a means to improve clinical outcomes in a number of complex procedures while lowering costs. The company is revolutionizing a new solution for orthopedic surgeons for human uses with their FDA-cleared magnesium-based platform bone void filler. For more information, visit BoneSolutions.net or contact Drew Diaz, BSI President/CEO, by phone 817-809-8850 or email diaz@bonesolutions.net.
###
